SAMSUNG ELECTRONICS Annual Revenues for December-2020 ending is 236.81 Trillion KRW
Annual Operating Income
35.99 Trillion KRW for Year ending December-2020
Annual Net Income
SAMSUNG ELECTRONICS Annual Net Income for December-2020 ending is 22.92 Trillion KRW
SAMSUNG ELECTRONICS Total Assets as on March-2020 is 299,850 Million USD
SAMSUNG ELECTRONICS Total Liabilities as on March-2020 is 76,393 Million USD
About Company Business:
Samsung Electronics is top number 1 company in South Korea by Market Capitalization as on 2020. As on Jan 1st 2020, Samsung Electronics has market cap of 320 Billion USD. Headquarters is in South Korea.
Post Apple company, Samsung Electronics is second biggest company in world in Electronics Manufacturing company. Samsung manufactures Mobiles, Laptops, Home Appliances, TVs, Refrigerators and many other Electronic Devices.
Samsung Biologics is Biopharmaceutical Manufacturing Company with headquarters in South Korea. It provides development, manufacturing , laboratory testing services at every stage for Biopharmaceutical products while meeting the evolving needs of the global healthcare industry. The company annual revenue is 601.61 million USD, annual operating income is 78.96 million USD and 2,590 employees as on 2020.
Naver Corporation is Internet Company and Search Engine services providing company and Web Portal Business with headquarters in South Korea.
The company services including line messenger, currently with over 200 million users from around the world. It products are online search engine and portal site and mobile messaging platform. The headquarters is in South Korea.
Celltrion is a Biopharmaceutical company. The headquarters is in South Korea.
Celltrion achieved what was thought impossible by launching the world’s first “antibody biosimilar” from a country with a relatively underdeveloped pharmaceutical sector. The company has pioneered numerous uncharted areas to stellar success, which it plans to follow up by continuing its growth as a global biopharmaceutical company with unique approaches to small molecule pharmaceuticals and new businesses such as the Ubiquitous-healthcare platform business.